Odisha government on Thursday declared Mucormycosis (Black Fungus) as a notifiable disease under the Epidemic Diseases Act 1897.
The decision came in view of the reported rise in the incidence of Mucormycosis (Black Fungus) amongst the COVID-19 patients those who were under Cortico Steroids and other Immunosuppressive drugs and also among the patients in the post COVID period across the State.
For its treatment and monitoring, a State Level Task Force Committee has already constituted by the Department. The Committee also monitors the incident of such patients admitted to the different hospitals of the State and formulates the guideline for early detection and management of such cases if detected.
Recently the Task Force has suggested a protocol for identification, treatment, and follow-up action in addition to public awareness. Further, the Committee recommends declaring Mucoremycosis (Black Fungus) as a notifiable disease under the Epidemic Diseases Act -1897 so that reports on all such suspected and confirmed cases shall be shared by all District Health Facilities to the Health and Family Welfare Department and subsequently to IDSP Surveillance System for monitoring.
Earlier, the Tamil Nadu government declared Black Fungus a notifiable disease under the Public Health Act, informed TN Health Secy J Radhakrishna on Thursday.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
Source link
